CoChat

Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Irritable bowel syndrome (IBS) is a common and chronic gastrointestinal disorder. Probiotics may have the potential to impact the management of IBS; however, the results of trials are conflicting. This study aimed to investigate whether a mixture of lactobacilli probiotics could improve abdominal symptoms in patients with unconstipated IBS. Fifty Vietnamese patients with unconstipated IBS were randomly assigned to either the probiotics or placebo groups. During the intervention, participants took the probiotic supplement, named Foodis Lactobacillus, or placebo capsule once a day. Patients recorded their subject global assessment (SGA) weekly and were assessed with the visual analogue scale (VAS) during the 4-week study period. Patients with SGA score of 2 points or more or a decrease of more than 30% in VAS score were considered responders. Patients who responded weekly for more than 2 of the 4 weeks were considered overall responders. There was no significant difference in demographic characteristics between the groups. Overall responder rates of improvement of global IBS symptoms assessed by SGA score were significantly higher in the probiotics group (80.8%) than in the placebo group (45.8%) (p = 0.009). The overall responder rates assessed by VAS score were also higher in the probiotics group (69.2%, 41.7%, p = 0.048). There were no adverse events in either group during the study period. Our findings suggest that the new combination of Lactobacilli appears to be promising in the relief of abdominal symptoms in Vietnamese patients with unconstipated IBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu11122887

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study design. SGA: Subject global assessment; VAS: Visual analogue score.
Figure 1 Study design. SGA: Subject global assessment; VAS: Visual analogue score.CC BY · PubMed Central
Figure 2 Flowchart of participants. IBS: Irritable bowel syndrome; IBS-C: IBS with predominant constipation.
Figure 2 Flowchart of participants. IBS: Irritable bowel syndrome; IBS-C: IBS with predominant constipation.CC BY · PubMed Central
Figure 3 Overall responder rates for improvement of overall IBS symptoms assessed by SGA score (A). Overall responder rates for improvement of abdominal pain assessed by VAS score (B). * p < 0.05, ** p < 0.01 compared to placebo. IBS: Irritable bowel syndrome; SGA: Subject global assessment; VAS: Visual analogue score.
Figure 3 Overall responder rates for improvement of overall IBS symptoms assessed by SGA score (A). Overall responder rates for improvement of abdominal pain assessed by VAS score (B). * p < 0.05, ** p < 0.01 compared to placebo. IBS: Irritable bowel syndrome; SGA: Subject global assessment; VAS: Visual analogue score.CC BY · PubMed Central
Figure 4 Weekly responder rates for improvement of (A) overall IBS symptom assessed by SGA score and (B) abdominal pain assessed by VAS score. * p < 0.05 compared to placebo. IBS: Irritable bowel syndrome; SGA: Subject global assessment; VAS: Visual analogue score.
Figure 4 Weekly responder rates for improvement of (A) overall IBS symptom assessed by SGA score and (B) abdominal pain assessed by VAS score. * p < 0.05 compared to placebo. IBS: Irritable bowel syndrome; SGA: Subject global assessment; VAS: Visual analogue score.CC BY · PubMed Central
Figure 5 Weekly changes in (A) overall IBS symptom assessed by SGA score and (B) abdominal pain assessed by VAS score. * p < 0.05 compared to placebo. IBS: Irritable bowel syndrome; SGA: Subject global assessment; VAS: Visual analogue score.
Figure 5 Weekly changes in (A) overall IBS symptom assessed by SGA score and (B) abdominal pain assessed by VAS score. * p < 0.05 compared to placebo. IBS: Irritable bowel syndrome; SGA: Subject global assessment; VAS: Visual analogue score.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 45

Metadata

Authors
Oh, J. H., Jang, Y. S., Kang, D., Chang, D. K., & Min, Y. W.
Affiliations
Samsung Medical Center (KR)
Corresponding author
Min, Yang Won
Venue
Nutrients
Publisher
MDPI AG
Published
2019-11-27
Volume
11
Issue
12
Pages
2887
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2990905783
Cited by
45
References
46
Citations by year
2026: 5 · 2025: 2 · 2024: 3 · 2023: 8 · 2022: 16 · 2021: 6 · 2020: 5
FWCI
6.15
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Ministry of Agriculture, Food and Rural Affairs (MAFRA) (316061-3)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
irritable bowel syndrome, lactobacilli, probiotics, abdominal symptoms, symptom relief, probiotic safety, Vietnamese patients
MeSH terms
Adult, Double-Blind Method, Female, Humans, Lactobacillus, Male, Placebos, Quality of Life, Vietnam, Abdominal Pain, Treatment Outcome, Probiotics, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.